CS logo
small CS logo
National Research Center For Preventive Medicine

Moscow, Russian Federation
Medical center in Moscow
Petroverigskiy Pereulok, 10, Moscow, 101990

About National Research Center For Preventive Medicine


"Сейчас Центр решает крайне актуальные задачи сохранения и укрепления здоровья россиян, снижения заболеваемости и смертности от основных хронических неинфекционных заболеваний. Научные сотрудники НМИЦ ПМ проводят эпидемиологический мониторинг основных факторов риска сердечно-сосудистых заболеваний, создают и внедряют новые методы и организационные формы первичной и вторичной профилактики хронических неинфекционных заболеваний, участвуют в разработке и реализации стратегии действий по созданию в России единой профилактической среды."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
National Research Center for Preventive Medicine
5
National Medical Research Center for Therapy and Preventive Medicine
4
Kowa Research Europe
3
Bayer
2
Kowa Research Institute, Inc.
2
Amgen
1
Gilead Sciences
1
Population Health Research Institute
1
Total Rows: 8

Clinical Trials at National Research Center For Preventive Medicine


During the past decade, National Research Center For Preventive Medicine conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 6 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 5 clinical trials were completed. i.e. 83.3% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11223311223322110011000000221122Started TrialsCompleted Trails2015201620172018201920202021202201234
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study to Compare the Efficacy of Pitavastatin With That of Atorvastatin in Lowering Cholesterol Levels
2005-10-01
2006-11-01
Completed
830
Study to Compare the Efficacy and Safety of Pitavastatin and Simvastatin
2005-09-01
2006-10-01
Completed
857
Long-Term Extension Study of Pitavastatin in Patients With Primary Hypercholesterolemia or Combined Dyslipidemia
2006-07-01
2007-11-01
Completed
1,355
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
2011-10-01
2015-02-01
Completed
2,651
Comparative Effects of Moxonidine on Bone Metabolism, Vascular and Cellular Aging in Hypertensive Postmenopausal Women
2015-04-01
2018-07-10
Completed
114
Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Normal Renal Function
2016-11-28
2019-06-24
Completed
551
Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Mild or Moderate Renal Impairment
2016-11-26
2019-07-05
Completed
471
Patient-reported Outcomes in Vericiguat-treated Patients With HFpEF
2018-06-15
2019-11-04
Completed
789

Rows per page:

1–19 of 19

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "National Research Center For Preventive Medicine" #1 sponsor was "National Research Center for Preventive Medicine" with 5 trials, followed by "National Medical Research Center for Therapy and Preventive Medicine" with 4 trials sponsored, "Kowa Research Europe" with 3 trials sponsored, "Bayer" with 2 trials sponsored and "Kowa Research Institute, Inc." with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "National Research Center For Preventive Medicine" #1 collaborator was "Moscow State University of Medicine and Dentistry" with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Canadian VIGOUR Centre" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator and "I.M. Sechenov First Moscow State Medical University" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.
Created with Highcharts 11.1.0Top Leading SponsorsNational ResearchCenter for PreventiveMedicine: 5National ResearchCenter for PreventiveMedicine: 5National MedicalResearch Center forTherapy and PreventiveMedicine: 4National MedicalResearch Center forTherapy and PreventiveMedicine: 4Kowa Research Europe: 3Kowa Research Europe: 3Bayer: 2Bayer: 2Kowa Research Institute, Inc.: 2Kowa Research Institute, Inc.: 2Amgen: 1Amgen: 1Gilead Sciences: 1Gilead Sciences: 1Population HealthResearch Institute: 1Population HealthResearch Institute: 1

Created with Highcharts 11.1.0Top CollaboratorsMoscow StateUniversity of Medicineand Dentistry: 2Moscow StateUniversity of Medicineand Dentistry: 2Bayer: 1Bayer: 1Canadian VIGOUR Centre: 1Canadian VIGOUR Centre: 1Duke Clinical ResearchInstitute: 1Duke Clinical ResearchInstitute: 1I.M. Sechenov FirstMoscow State MedicalUniversity: 1I.M. Sechenov FirstMoscow State MedicalUniversity: 1Merck Sharp & Dohme LLC: 1Merck Sharp & Dohme LLC: 1

Clinical Trials Conditions at National Research Center For Preventive Medicine


According to Clinical.Site data, the most researched conditions in "National Research Center For Preventive Medicine" are "Atrial Fibrillation" (3 trials), "Dyslipidemia" (3 trials), "Adherence, Patient" (2 trials), "Hypercholesterolemia" (2 trials) and "Severe Hypertriglyceridemia" (2 trials). Many other conditions were trialed in "National Research Center For Preventive Medicine" in a lesser frequency.

Clinical Trials Intervention Types at National Research Center For Preventive Medicine


Most popular intervention types in "National Research Center For Preventive Medicine" are "Drug" (12 trials), "Other" (3 trials), "Behavioral" (2 trials), "Diagnostic Test" (2 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Pitavastatin" (4 trials), "Placebo" (4 trials), "Fenofibrate" (2 trials), "K-877" (2 trials) and "Placebo (for K-877)" (2 trials). Other intervention names were less common.

Clinical Trials Genders at National Research Center For Preventive Medicine


The vast majority of trials in "National Research Center For Preventive Medicine" are 18 trials for "All" genders and 1 trials for "Female" genders.

Clinical Trials Status at National Research Center For Preventive Medicine


Currently, there are NaN active trials in "National Research Center For Preventive Medicine". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in National Research Center For Preventive Medicine, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in National Research Center For Preventive Medicine, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 9Phase 3: 9Not Applicable: 3Not Applicable: 3Phase 2: 1Phase 2: 1Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 12Completed: 12Active, not recruiting: 4Active, not recruiting: 4Recruiting: 3Recruiting: 3